Company news
Oxford Nanopore Technologies Plc (LSE:ONT) news
Oxford Nanopore Technologies Plc news releases on 6ix. Latest, Oct 2, 2026: IP : completes c.£21m partial realisation in Oxford Nanopore
Press releases & updates
IP : completes c.£21m partial realisation in Oxford Nanopore
October 2, 2026
IP Group completes partial realisation in ONT
October 2, 2026
Holding(s) in Company
October 2, 2026
Issue of Equity and Total Voting Rights
October 1, 2026
Preliminary injunction against MGI Tech GmbH
September 16, 2026
Appointment of CDPO
August 25, 2026
LTIP awards; Director/PDMR Notification
August 20, 2026
Interim results for the 6 months ended 30 June 26
August 19, 2026
Oxford Nanopore strengthens executive team
May 21, 2026
Oxford Nanopore Technologies : Proxy Form for 2026 AGM
May 1, 2026
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration
April 15, 2026
Block Admission Application
March 26, 2026
Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan
March 17, 2026
Issue of Equity; Director/PDMR Shareholding
March 9, 2026
Upcoming Investor Events and Conferences
March 4, 2026
Grant of LTIP awards; Director/PDMR Notification
March 3, 2026
Director/PDMR Shareholding
March 3, 2026
Issue of Equity and Total Voting Rights
March 2, 2026
Annual results for the year ended 31 December 2025
March 2, 2026
Update on legal action against MGI Australia
February 27, 2026
Director Declaration - John O'Higgins
February 27, 2026
Share Incentive Plan - Director/PDMR Shareholding
February 12, 2026
Full Year Trading Update and Notice of Results
January 12, 2026
Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe
January 12, 2026
AGM Post-Meeting Shareholder Engagement Update
December 8, 2025
Appointment of Francis Van Parys as CEO
December 8, 2025
Upcoming investor conferences
November 27, 2025
ONT postpones investor event; reaffirms guidance
November 7, 2025
Upcoming Investor Conferences and Events
October 16, 2025
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
October 9, 2025
Block listing Interim Review
October 6, 2025
Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows
September 10, 2025
Interim results for the 6 months ended 30 June 25
September 2, 2025
Share Incentive Plan - Director/PDMR Notification
August 13, 2025
Chief Executive Officer Succession
August 11, 2025
Result of Audit Tender
August 8, 2025
ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
August 7, 2025
Commencement of legal action against MGI Australia
August 6, 2025
Holding(s) in Company
July 29, 2025
Half Year Trading Update and Notice of Results
July 21, 2025
Publication of 2024 Sustainability Report
July 4, 2025
Changes in Composition of Remuneration Committee
June 5, 2025
Result of AGM
June 4, 2025
London Calling Technology Update
May 22, 2025
Founder LTIP - Director/PDMR Notification
April 30, 2025
Publication of Annual Report and Notice of AGM
April 30, 2025
Director/PDMR Shareholding - LTIP and DBP awards
April 14, 2025
Oxford Nanopore and Cepheid collaboration
April 9, 2025
SIP PDMR Notification - Correction
March 14, 2025
Annual results for the year ended 31 December 2024
March 4, 2025